Form 4: Vicor Corp Director D'Amico Trades Shares
Insider Transaction Report
Vicor Corp Director Andrew D'Amico reported transactions involving the purchase of 1,216 shares and the sale of various tranches of common stock on June 22, 2026.
Summary
- Andrew D'Amico, a Director at Vicor Corp (VICR), engaged in significant stock transactions on June 22, 2026.
- D'Amico acquired 1,216 shares of common stock at a price of $32.89 per share.
- Concurrently, D'Amico sold a total of 2,316 shares of common stock in multiple transactions.
- The sales occurred at weighted average prices ranging from $354.12 to $367.10 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on September 12, 2024.
- Additionally, D'Amico was granted 548 non-qualified stock options on June 22, 2026, with an exercise price of $365.53, vesting over five years.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While the director acquired shares, the significant volume of sales under a pre-arranged plan indicates profit-taking or portfolio diversification rather than a strong conviction buy signal.
Positives
- Director acquired 1,216 shares of common stock, indicating a potential belief in the company's value.
- The acquisition price of $32.89 per share is significantly lower than the sale prices, suggesting a favorable entry point for these shares.
- The grant of 548 stock options on June 22, 2026, with a five-year vesting period, aligns management incentives with long-term company performance.
Negatives
- Director sold a substantial number of shares (2,316) at prices significantly higher than the acquisition price, which could be interpreted as taking profits.
- The sales were executed under a pre-arranged trading plan, which is standard but represents a divestment of holdings.
Risks
- The Rule 10b5-1 trading plan, while providing an affirmative defense against insider trading allegations, still involves the sale of company stock by a director.
- The significant number of shares sold could be perceived negatively by the market, potentially impacting share price if not adequately explained by the plan's parameters.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.
Management Comments
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
- Granted under the Company's Amended and Restated 2000 Stock Option and Incentive Plan on June 22, 2026 and vest over a five year period.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are common in the semiconductor industry as executives manage their personal portfolios while adhering to regulatory requirements. The timing and volume of such trades can still influence market perception.
Stakeholder Impact
- Shareholders: May interpret the director's sales as a signal, potentially leading to short-term price fluctuations, though the Rule 10b5-1 plan mitigates concerns about insider trading.
- Employees: The stock option grant reinforces the alignment of employee and executive interests with the company's long-term success.
- Management: The transactions reflect standard personal financial planning for executives holding significant company stock.
Next Steps
- The stock options granted on June 22, 2026, will vest over a five-year period.
- Future transactions by Andrew D'Amico will be subject to the terms of his Rule 10b5-1 trading plan or new disclosures.
Key Dates
| Date | Description |
|---|---|
| 09/12/2024 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 06/21/2026 | Earliest date for exercisability and expiration of certain stock options. |
| 06/22/2026 | Date of earliest transaction reported, including stock acquisition, stock sales, and stock option grant. |
| 06/22/2034 | Expiration date for certain stock options. |
| 06/22/2036 | Expiration date for granted stock options. |
| 06/24/2026 | Date the Form 4 was signed and filed. |
Keywords
Vicor Corp, VICR, Form 4, Insider Trading, Stock Options, Rule 10b5-1, Director Transactions, Beneficial Ownership, Stock Sales, Stock Purchases
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.